Your browser doesn't support javascript.
loading
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.
Vivarelli, Emanuele; Matucci, Andrea; Lucenteforte, Ersilia; Bormioli, Susanna; Virgili, Gianni; Trotta, Michele; Spinicci, Michele; Bartoloni, Alessandro; Zammarchi, Lorenzo; Peris, Adriano; Pieralli, Filippo; Lavorini, Federico; Fontanari, Paolo; Morettini, Alessandro; Nozzoli, Carlo; Poggesi, Loredana; Rossi, Oliviero; Annunziato, Francesco; Almerigogna, Fabio; Vultaggio, Alessandra.
Afiliação
  • Vivarelli E; Unit of Immunoallergology, Careggi University Hospital, Florence, Italy.
  • Matucci A; Unit of Immunoallergology, Careggi University Hospital, Florence, Italy.
  • Lucenteforte E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Bormioli S; Unit of Immunoallergology, Careggi University Hospital, Florence, Italy.
  • Virgili G; Department of Ophthalmology, Careggi University Hospital, Florence, Italy.
  • Trotta M; Unit of Infectious and Tropical Diseases, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
  • Spinicci M; Unit of Infectious and Tropical Diseases, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
  • Bartoloni A; Unit of Infectious and Tropical Diseases, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
  • Zammarchi L; Unit of Infectious and Tropical Diseases, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
  • Peris A; Intensive Care Unit, Regional ECMO Referral Center, Careggi University Hospital, Florence, Italy.
  • Pieralli F; Intermediate Care Unit, Careggi University Hospital, Florence, Italy.
  • Lavorini F; Pneumology and Intensive Care Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Fontanari P; Cardiac Anesthesia and Intensive Care Unit, Careggi University Hospital, Florence, Italy.
  • Morettini A; Internal Medicine Unit2, Careggi University Hospital, Florence, Italy.
  • Nozzoli C; Internal Medicine Unit1, Careggi University Hospital, Florence, Italy.
  • Poggesi L; Internal Medicine Unit3, Careggi University Hospital, Florence, Italy.
  • Rossi O; Unit of Immunoallergology, Careggi University Hospital, Florence, Italy.
  • Annunziato F; Department of Experimental and Clinical Medicine, Flow Cytometry Diagnostic Center, and Immunotherapy (CDCI), Careggi University Hospital, Florence, Italy.
  • Almerigogna F; Unit of Immunoallergology, Careggi University Hospital, Florence, Italy.
  • Vultaggio A; Unit of Immunoallergology, Careggi University Hospital, Florence, Italy - vultaggioalessandra@gmail.com.
Panminerva Med ; 65(4): 473-478, 2023 Dec.
Article em En | MEDLINE | ID: mdl-35274908
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Panminerva Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Panminerva Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália